Skip to content

Ultrasound-guided external oblique intercostal block improves analgesia after hepatectomy: a randomized controlled trial

Ultrasound-guided external oblique intercostal block improves analgesia after hepatectomy: a randomized controlled trial - external oblique intercostal block improves analgesia after hepatectomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071927
Enrollment
Unknown
Registered
2023-05-29
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia

Interventions

Group NS:injection of NS
Group Ropivacaine:injection of ropivacaine

Sponsors

Department of Anesthesiology,Zhongshan Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 patients aged 18-80 years, 2 ASA grade I-III, 3 first time hepatectomy due to hepatocellular carcinoma or hepatic hemangioma 4 there were one or more of the following abnormalities in the preoperative coagulation function test: international standard ratio (INR)=1.4, platelet count 38s, the activated partial thromboplastin time (APTT) should be within the normal range (200 IU/kg/d) 5 Use of anticoagulants or antiplatelet drug which did not satisfy the safe time of epidural block 6 large-scale hepatectomy (3 hepatic segments) due to the large tumor, and the anesthesiologist was concerned about the postoperative coagulation function, it was considered that epidural puncture should not be performed, 7 patients had enough language communication ability to complete postoperative follow-up, 8 patients volunteered to be tested and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1 history of local anesthetic allergy, 2 chronic pain, long-term use of opioids, 3 block site infection, 4 combined surgery (except hepatectomy plus cholecystectomy) , 5 pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
Consumption of hydromorphone 24 h after operation;

Secondary

MeasureTime frame
dermatomal sensory coverage;Consumption of hydromorphone 12 h after operation;NRS score;Incidence of rebound pain;Rescue dose of hydromorphone in PACU;The time of the first PCIA injection of analgesic after operation;the incidence of analgesia-related adverse events in PACU and 24 h postoperatively;QoR-15 score;adverse events related to nerve block;

Countries

China

Contacts

Public ContactXiaoguang Zhang

Zhongshan Hospital Affiliated to Fudan University

zhang.xiaoguang@zs-hospital.sh.cn+86 136 4199 5733

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026